Letters Section Editor: Stephen J. Lurie, MD, PhD, Senior Editor.
To the Editor: Dr Mahadevia and colleagues1 concluded that helical computed tomography (CT)
should not be used as a screening tool for lung cancer. They based their conclusion
on the results of their cost-effectiveness analysis, which relied on several
assumptions about the costs and benefits of helical CT screening. I believe
that these assumptions were overly optimistic, however, and that helical CT
is thus probably even less effective than the authors conclude.
Reich J. Cost-effectiveness of Screening for Lung Cancer—Reply. JAMA. 2003;289(18):2357. doi:10.1001/jama.289.18.2357-a